Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients
Jun Li(Zhengzhou University), Yongjun Guo(Tianjin Agricultural University), Sile Han(Zhengzhou University), Qingxin Xia(Zhengzhou University), Hongle Li(Shanghai Jiao Tong University), Bing Wei(Henan University of Engineering), Ping Wang(Chinese Academy of Inspection and Quarantine), Jie Ma(Zhengzhou University), Yi Wang(Beijing Botanical Garden), Yanlin Luo(Zhengzhou University), Cuiyun Zhang(Zhengzhou University), Li Wang(China Three Gorges University), Xiaoyan Wang(Ministry of Education of the People's Republic of China)
Cited by 0
Related Papers
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer
|JAMA Oncology|2023|165
Model-based understanding of single-cell CRISPR screening
|Nature Communications|2019|107